Investigation of Antiphosphatidyl-Serine Antibody and Antiphosphatidyl-Inositol Antibody in Ischemic Stroke Patients

Table 2

Clinical and laboratory findings in patients with PI and PS.

Case	Age	Gender	PI	PS	β2-GPIaCL	ANA	Type of
	(y)						stroke
1	68	Male	0.5	1.4	(−)	D80×	L
2	63	Male	1.1	1	(−)	D80×	C
3	72	Male	2.1	0.6	(−)	(−)	L
4	58	Male	1.9	1.7	(−)	D80×	A
5	64	Female	1.6	1.5	(−)	D80×	L
6	78	Male	0.8	1.3	(−)	D40×	L
7	48.	Female	1.9	1.5	(−)	D640×	L
8	66	Male	1	0.5	(−)	(−)	L
9	43	Male	1.8	0.7	(−)	N160×	A
10	71	Male	1.1	1	(−)	SP40×	L
11	70	Male	1.9	0.8	(−)	D80×	A
12	60	Male	1.4	1.1	(−)	D40×	A
13	64	Male	1.1	0.9	(−)	SP40×	L
14	49	Male	2.1	0.9	0𝑥03000(−) LA +	(−)	A
15	58	Male	1.5	1.4	(−)	D+N40×	A
16	68	Female	1.5	1.2	(−)	D160×	L
17	53	Female	8.1	1.1	(−)	SP N80×	A
18	72	Female	1.5	1	(−)	SP80×	L
19	71	Male	1	0.7	(−)	(−)	L
20	73	Female	1.3	0.8	(−)	SP80×	L
21	64.	Female	1.1	1.3	(−)	D640×	A
22	81	Male	1	0.9	(−)	SP40×	L
23	76.	Male	1.3	1.6	(−)	SP40×	A
24	80	Male	1	1.3	(−)	D80×	A
25	83	Female	0.7	1.4	(−)	(−)	A
26	44	Male	2.1	1.3	(−)	D2560×	C
27	52.	Male	2.1	2.9	(−)	SP40×	A
28	79	Male	0.7	1.1	(−)	(−)	L
29	76	Female	0.8	1.1	(−)	D80×	L
30	65	Male	0.8	1.1	(−)	SP40×	L
31	63.	Female	0.5	1.8	(−)	SP40×	C
32	31	Male	1.4	1.3	0𝑥03000(+) LA +	D320×	A
33	50	Male	0.5	1.1	0𝑥03000(+) LA +	(−)	A
34	46	Female	5.2	7.6	(−)	SP80×	A

L: lacunar infarction, A: atherothrombotic infarction, C: cardiogenic embolism D: diffuse pattern, SP: speckled pattern, and N: nucleolar pattern.